SNOA offering history
Every offering-related filing in Sonoma Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 973 filings back to Jan 15, 2002.
| Date | Filing | What it means | |
|---|---|---|---|
| Jun 18, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 27, 2026 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Apr 23, 2026 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 23, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 17, 2026 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Sep 26, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 20, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 23, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 27, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 8, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 15, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 22, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 20, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 3, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 30, 2023 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Oct 26, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 13, 2023 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 19, 2023 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Feb 24, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 23, 2022 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Sep 3, 2021 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jul 30, 2021 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 23, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 22, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 15, 2020 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Nov 24, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Nov 27, 2019 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 26, 2019 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 20, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 16, 2018 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Nov 16, 2018 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 7, 2018 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Oct 12, 2018 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Mar 5, 2018 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 2, 2018 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 8, 2017 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 28, 2017 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 27, 2017 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 17, 2017 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Nov 9, 2017 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
SNOA offering FAQ
When did SNOA last execute an offering?
Per SEC filings, Sonoma Pharmaceuticals, Inc.'s most recent priced offering document is a 424B5 filed 2026-06-18. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did SNOA last announce or register an offering?
The most recent registration is a S-1/A filed 2026-04-23. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.